Results 161 to 170 of about 5,062,841 (308)

Current Issues of Disaster Medicine Service According to the 2016–2017 Audit Results

Медицина катастроф, 2018
Belova A.B., Chubayko V.G., Osadchiy K.N., Yuvakaev I.S., Bobiy B.V., Sakhno I.I., Chernyak S.I.   +6 more
doaj  

Are All Competencies Equal in the Eyes of Residents? A Multicenter Study of Emergency Medicine Residents’ Interest in Feedback [PDF]

, 2017
Suzanne Bentley, Kevin Hu, Anne Messman, Tiffany Moadel, Sorabh Khandelwal, Heather Streich, Joan Noelker   +6 more
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

RESULTS OF SERVICE FOR DISASTER MEDICINE OF HEALTH MINISTRY OF THE RUSSIAN FEDERATION ACTIVITY IN 2017

Медицина катастроф, 2018
Chubayko V.G., Kryukov V.I., Baranova N.N., Belova A.B., Yuvakaev I.S., Radchenko I.V., Magazeyshchikova N.G.   +6 more
doaj  

Health behaviors, lifestyle factors, and healthcare challenges in family medicine: a comprehensive review of recent evidence from Asian populations. [PDF]

Korean J Fam Med
Son JS.
europepmc   +1 more source

Exercise is Medicine Global Health Initiative for All Ages [PDF]

, 2017
Zerf Mohammed
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

A bi-specific CAR-T cell therapy targeting CD19 and CD22 in relapsed or refractory B-ALL. [PDF]

Clin Exp Med
Ma Q, Wei R, Wang Q, Jiang S, Wu Y, Min C, Guo S, Zhang Y, Sun X, Wu H, Sun X, Xiang F, Xiao M, Cheng Z.   +13 more
europepmc   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Bench to all Bedsides in Genomics and Precision Medicine

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Catherine Tcheandjieu, Christopher Robinson, Pradeep Natarajan   +2 more
doaj   +1 more source